RLMD Competitors & Alternatives
Compare Relmada Therapeutics Inc with similar stocks in the same industry
Biotechnology
RLMD
Main Stock$3.29
Tradestie Score
76
Market Cap
$71.69M
Analyst Upside
+226.7%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$11.85
|
$407.71M | - | 68 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$10.49
|
$386.68M | - | 61 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$6.46
|
$382.04M | - | 59 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$12.90
|
$371.64M | - | 61 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$14.92
|
$354.45M | - | 47 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$39.42
|
$353.70M | 410.0 | 46 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.43
|
$350.98M | - | 62 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.81
|
$332.96M | - | 52 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.99
|
$328.62M | - | 51 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.59
|
$307.12M | - | 61 | Compare |
More RLMD Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry